Hipp, Joerg F. https://orcid.org/0000-0002-7875-2988
Chamberlain, Stormy
DiStefano, Charlotte
Frohlich, Joel
Hernandez, Maria-Clemencia https://orcid.org/0000-0003-1621-4188
Saravanapandian, Vidya
Vogel-Farley, Vanessa https://orcid.org/0000-0002-1010-5944
Goeldner, Celia
Jeste, Shafali S.
Article History
Received: 3 July 2025
Revised: 18 May 2026
Accepted: 8 June 2026
First Online: 15 June 2026
Competing interests
: Joerg F. Hipp, Stormy Chamberlain, Celia Goeldner, and Maria-Clemencia Hernandez are full-time employees of F. Hoffmann-La Roche Ltd.; Joel Frohlich is a former employee of F. Hoffmann-La Roche Ltd (October 2016 – July 2017). Joel Frohlich is a consultant for IAMA Therapeutics and receives funding from the Bial Foundation, unrelated to this work. All other authors report no biomedical financial interests or potential conflicts of interest.